A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

NCT07255872 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: BL-M11D1
DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Venetoclax
DRUG: Azacitidine

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]